A citation-based method for searching scientific literature

E P Hoffman, L M Kunkel, C Angelini, A Clarke, M Johnson, J B Harris. Neurology 1989
Times Cited: 228







List of co-cited articles
810 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.
A H Beggs, E P Hoffman, J R Snyder, K Arahata, L Specht, F Shapiro, C Angelini, H Sugita, L M Kunkel. Am J Hum Genet 1991
355
29


Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy.
E P Hoffman, K H Fischbeck, R H Brown, M Johnson, R Medori, J D Loike, J B Harris, R Waterston, M Brooke, L Specht. N Engl J Med 1988
787
28

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.
A P Monaco, C J Bertelson, S Liechti-Gallati, H Moser, L M Kunkel. Genomics 1988
904
24

The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
M Koenig, A H Beggs, M Moyer, S Scherpf, K Heindrich, T Bettecken, G Meng, C R Müller, M Lindlöf, H Kaariainen,[...]. Am J Hum Genet 1989
801
23

Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction.
A H Beggs, M Koenig, F M Boyce, L M Kunkel. Hum Genet 1990
617
20

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin.
S B England, L V Nicholson, M A Johnson, S M Forrest, D R Love, E E Zubrzycka-Gaarn, D E Bulman, J B Harris, K E Davies. Nature 1990
461
15

Dystrophinopathy in isolated cases of myopathy in females.
E P Hoffman, K Arahata, C Minetti, E Bonilla, L P Rowland. Neurology 1992
133
14

Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates.
G P Comi, A Prelle, N Bresolin, M Moggio, A Bardoni, A Gallanti, G Vita, A Toscano, M T Ferro, A Bordoni. Brain 1994
82
15


Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.
J S Chamberlain, R A Gibbs, J E Ranier, P N Nguyen, C T Caskey. Nucleic Acids Res 1988
877
12

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.
Maria Kinali, Virginia Arechavala-Gomeza, Lucy Feng, Sebahattin Cirak, David Hunt, Carl Adkin, Michela Guglieri, Emma Ashton, Stephen Abbs, Petros Nihoyannopoulos,[...]. Lancet Neurol 2009
483
12

Local dystrophin restoration with antisense oligonucleotide PRO051.
Judith C van Deutekom, Anneke A Janson, Ieke B Ginjaar, Wendy S Frankhuizen, Annemieke Aartsma-Rus, Mattie Bremmer-Bout, Johan T den Dunnen, Klaas Koop, Anneke J van der Kooi, Nathalie M Goemans,[...]. N Engl J Med 2007
592
12

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
Sebahattin Cirak, Virginia Arechavala-Gomeza, Michela Guglieri, Lucy Feng, Silvia Torelli, Karen Anthony, Stephen Abbs, Maria Elena Garralda, John Bourke, Dominic J Wells,[...]. Lancet 2011
595
12


Quadriceps myopathy: forme fruste of Becker muscular dystrophy.
N Sunohara, K Arahata, E P Hoffman, H Yamada, J Nishimiya, E Arikawa, M Kaido, I Nonaka, H Sugita. Ann Neurol 1990
76
14

Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.
Annemieke Aartsma-Rus, Judith C T Van Deutekom, Ivo F Fokkema, Gert-Jan B Van Ommen, Johan T Den Dunnen. Muscle Nerve 2006
386
11

Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene.
S M Gospe, R P Lazaro, N S Lava, P M Grootscholten, M O Scott, K H Fischbeck. Neurology 1989
133
10

Clinical-molecular correlation in 104 mild X-linked muscular dystrophy patients: characterization of sub-clinical phenotypes.
C Angelini, M Fanin, E Pegoraro, M P Freda, M Cadaldini, F Martinello. Neuromuscul Disord 1994
39
25

Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs.
Toshifumi Yokota, Qi-Long Lu, Terence Partridge, Masanori Kobayashi, Akinori Nakamura, Shińichi Takeda, Eric Hoffman. Ann Neurol 2009
274
10

Systemic administration of PRO051 in Duchenne's muscular dystrophy.
Nathalie M Goemans, Mar Tulinius, Johanna T van den Akker, Brigitte E Burm, Peter F Ekhart, Niki Heuvelmans, Tjadine Holling, Anneke A Janson, Gerard J Platenburg, Jessica A Sipkens,[...]. N Engl J Med 2011
505
10

Dystrophin levels and clinical severity in Becker muscular dystrophy patients.
J C van den Bergen, B H Wokke, A A Janson, S G van Duinen, M A Hulsker, H B Ginjaar, J C van Deutekom, A Aartsma-Rus, H E Kan, J J Verschuuren. J Neurol Neurosurg Psychiatry 2014
67
14

Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy.
S Noguchi, E M McNally, K Ben Othmane, Y Hagiwara, Y Mizuno, M Yoshida, H Yamamoto, C G Bönnemann, E Gussoni, P H Denton,[...]. Science 1995
445
9

Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses.
K Arahata, E P Hoffman, L M Kunkel, S Ishiura, T Tsukahara, T Ishihara, N Sunohara, I Nonaka, E Ozawa, H Sugita. Proc Natl Acad Sci U S A 1989
148
9

Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.
L V Nicholson, M A Johnson, K M Bushby, D Gardner-Medwin, A Curtis, I B Ginjaar, J T den Dunnen, J L Welch, T J Butler, E Bakker. J Med Genet 1993
68
13

Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.
F Muntoni, M Cau, A Ganau, R Congiu, G Arvedi, A Mateddu, M G Marrosu, C Cianchetti, G Realdi, A Cao. N Engl J Med 1993
317
9

Becker muscular dystrophy with onset after 60 years.
A Heald, L V Anderson, K M Bushby, P J Shaw. Neurology 1994
50
18


Dystrophin and mutations: one gene, several proteins, multiple phenotypes.
Francesco Muntoni, Silvia Torelli, Alessandra Ferlini. Lancet Neurol 2003
582
9

Eteplirsen for the treatment of Duchenne muscular dystrophy.
Jerry R Mendell, Louise R Rodino-Klapac, Zarife Sahenk, Kandice Roush, Loren Bird, Linda P Lowes, Lindsay Alfano, Ann Maria Gomez, Sarah Lewis, Janaiah Kota,[...]. Ann Neurol 2013
431
9

Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy.
S L Roberds, F Leturcq, V Allamand, F Piccolo, M Jeanpierre, R D Anderson, L E Lim, J C Lee, F M Tomé, N B Romero. Cell 1994
419
8

Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei.
E Pegoraro, R N Schimke, C Garcia, H Stern, M Cadaldini, C Angelini, E Barbosa, J Carroll, W A Marks, H E Neville,[...]. Neurology 1995
75
10

Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications.
J T Den Dunnen, P M Grootscholten, E Bakker, L A Blonden, H B Ginjaar, M C Wapenaar, H M van Paassen, C van Broeckhoven, P L Pearson, G J van Ommen. Am J Hum Genet 1989
454
8

Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis.
R Gold, W Kress, B Meurers, G Meng, H Reichmann, C R Müller. Muscle Nerve 1992
41
19

Dilating cardiomyopathy as the expression of Xp21 Becker type muscular dystrophy.
L Palmucci, C Doriguzzi, T Mongini, L Chiadò-Piat, G Restagno, A Carbonara, V Paolillo. J Neurol Sci 1992
43
18


Exercise intolerance and recurrent myoglobinuria as the only expression of Xp21 Becker type muscular dystrophy.
C Doriguzzi, L Palmucci, T Mongini, L Chiadò-Piat, G Restagno, M Ferrone. J Neurol 1993
39
20

The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities.
K M Bushby, D Gardner-Medwin, L V Nicholson, M A Johnson, I D Haggerty, N J Cleghorn, J B Harris, S S Bhattacharya. J Neurol 1993
90
8

Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human.
Marcella Neri, Silvia Torelli, Sue Brown, Isabella Ugo, Patrizia Sabatelli, Luciano Merlini, Pietro Spitali, Paola Rimessi, Francesca Gualandi, Caroline Sewry,[...]. Neuromuscul Disord 2007
113
8

Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase.
Sylvie Tuffery-Giraud, Christophe Béroud, France Leturcq, Rabah Ben Yaou, Dalil Hamroun, Laurence Michel-Calemard, Marie-Pierre Moizard, Rafaëlle Bernard, Mireille Cossée, Pierre Boisseau,[...]. Hum Mutat 2009
207
8

The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy.
G Nigro, L I Comi, L Politano, R J Bain. Int J Cardiol 1990
398
8

Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study.
Thomas Voit, Haluk Topaloglu, Volker Straub, Francesco Muntoni, Nicolas Deconinck, Giles Campion, Sjef J De Kimpe, Michelle Eagle, Michela Guglieri, Steve Hood,[...]. Lancet Neurol 2014
215
8

Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex.
C G Bönnemann, R Modi, S Noguchi, Y Mizuno, M Yoshida, E Gussoni, E M McNally, D J Duggan, C Angelini, E P Hoffman. Nat Genet 1995
387
7

Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.
E Bonilla, C E Samitt, A F Miranda, A P Hays, G Salviati, S DiMauro, L M Kunkel, E P Hoffman, L P Rowland. Cell 1988
562
7

Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A.
I Richard, O Broux, V Allamand, F Fougerousse, N Chiannilkulchai, N Bourg, L Brenguier, C Devaud, P Pasturaud, C Roudaut. Cell 1995
774
7

Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.
K Arahata, S Ishiura, T Ishiguro, T Tsukahara, Y Suhara, C Eguchi, T Ishihara, I Nonaka, E Ozawa, H Sugita. Nature 1988
549
7

Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy.
P Melacini, M Fanin, G A Danieli, C Villanova, F Martinello, M Miorin, M P Freda, M Miorelli, M L Mostacciuolo, G Fasoli,[...]. Circulation 1996
126
7

X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus.
J A Towbin, J F Hejtmancik, P Brink, B Gelb, X M Zhu, J S Chamberlain, E R McCabe, M Swift. Circulation 1993
367
7

Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12.
L E Lim, F Duclos, O Broux, N Bourg, Y Sunada, V Allamand, J Meyer, I Richard, C Moomaw, C Slaughter. Nat Genet 1995
405
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.